A Cluster Randomized Trial to Evaluate Long Lasting Insecticidal Hammocks to Prevent Forest Malaria in Vietnam

NCT00853281 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18646

Last updated 2010-09-14

No results posted yet for this study

Summary

In Central Vietnam, forest malaria remains difficult to control due to the complex interactions between human, vector and environmental factors. Untreated bednets had a significantly protecting effect for villagers, except for those regularly sleeping in the forest, who suffer a significantly higher number of clinical attacks. Thus, there is need to target this high-risk group with new intervention based on long-lasting insecticidal materials. Hammocks are extensively used by people working in the forest, therefore long-lasting insecticidal hammocks (LLIH) could achieve a good individual protection.

The Investigators proposed to evaluate their effectiveness in a community-based trial, comparing them to the standard vector control methods (insecticide-treated nets).

Conditions

Interventions

OTHER

Hammocks with LLIN

Locally-made hammocks covered with long lasting insecticidal nel (LLIN)

OTHER

Standard vector control measures

Insectice-treated net

Sponsors & Collaborators

  • National Institute of Malariology, Parasitology and Entomology, Vietnam

    collaborator OTHER_GOV
  • London School of Hygiene and Tropical Medicine

    collaborator OTHER
  • Institute of Tropical Medicine, Belgium

    lead OTHER

Principal Investigators

  • Annette Erhart, MD · Institute of Tropical Medicine

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2006-12-31
Completion
2007-06-30

Countries

  • Vietnam

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00853281 on ClinicalTrials.gov